Literature DB >> 1821488

Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study.

C R Lupica1, R F Berman, M F Jarvis.   

Abstract

Chronic exposure to adenosine receptor antagonists results in an upregulation of brain adenosine A1 receptors as measured by traditional radioligand binding techniques. In the present study, quantitative receptor autoradiography was used to characterize alterations in rat brain adenosine A1 and A2 receptors following the repeated administration of high doses of theophylline. Daily administration of theophylline (75 or 100 mg/kg) markedly increased (125-150% of control) 1 nM [3H]cyclohexyladenosine binding to adenosine A1 receptors in specific cellular layers of the hippocampus, thalamus, and cerebellum with other brain regions showing more moderate increases in binding. By contrast, this chronic theophylline treatment did not produce any significant alterations in the binding of 4 nM [3H]CGS 21680 to adenosine A2 receptors, which were exclusively localized in the striatal region. This apparent differential sensitivity of adenosine receptor subtypes to chronic antagonist treatment suggests a possible intrinsic difference in the regulation of these receptor subtypes which may also be specific to particular brain regions. These results are discussed in relationship to other recent observations, indicating that the pattern of agonist binding to adenosine receptors may be regulated by a differential extent of coupling between adenosine receptors and G-binding proteins in different brain regions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821488     DOI: 10.1002/syn.890090203

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  11 in total

1.  Changes in the biochemical profiles of mid-cervically located adenosine A1 receptors after repeated theophylline administration in adult rats.

Authors:  Rubabe S Saharan; Kwaku D Nantwi
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

2.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

3.  Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression.

Authors:  K Biber; K N Klotz; M Berger; P J Gebicke-Härter; D van Calker
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

Review 4.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

5.  Modulation of adenosine receptors by [60]fullerene hydrosoluble derivative in SK-N-MC cells.

Authors:  Davide Giust; David León; Inmaculada Ballesteros-Yañez; Tatiana Da Ros; José Luis Albasanz; Mairena Martín
Journal:  ACS Chem Neurosci       Date:  2011-04-15       Impact factor: 4.418

6.  Caffeine attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Holly M Brothers; Yannick Marchalant; Gary L Wenk
Journal:  Neurosci Lett       Date:  2010-06-10       Impact factor: 3.046

7.  Behavioural effects of adenosine locally applied into ventral hippocampus of adult male rats.

Authors:  S L Salas; F A Redmond; E O Alvarez
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  Genetically controlled upregulation of adenosine A(1) receptor expression enhances the survival of primary cortical neurons.

Authors:  Tsvetan Serchov; Hasan-Cem Atas; Claus Normann; Dietrich van Calker; Knut Biber
Journal:  Mol Neurobiol       Date:  2012-08-17       Impact factor: 5.590

9.  Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.

Authors:  D K Von Lubitz; R C Lin; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-12-20       Impact factor: 4.432

Review 10.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.